US Patent Issued to Universitat Zu Lubeck on Nov. 25 for "Antisense drug against the human intercellular adhesion molecule 1 (ICAM-1)" (German Inventors)

ALEXANDRIA, Va., Nov. 25 -- United States Patent no. 12,480,128, issued on Nov. 25, was assigned to Universitat Zu Lubeck (Lubeck, Germany).

"Antisense drug against the human intercellular adhesion molecule 1 (ICAM-1)" was invented by Georg Sczakiel (GroB Gronau, Germany) and Rosel Kretschmer-Kazemi Far (Lubeck, Germany).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a specific antisense oligonucleotide which inhibits the expression of the adhesion molecule ICAM-1 in human cells. The present invention further relates to a vector containing said oligonucleotide and a host cell containing said vector or oligonucleotide and a pharmaceutical composition containing said oligonucleo...